Skip to content
Meta-analysis Open access

Adjunctive hyperbaric oxygen therapy for post-stroke cognitive impairment: a systematic review and meta-analysis of randomized controlled trials

Oct 2026 · Frontiers in Neurology · Vol 17 · 0 citations · 40 references
Medicine

TL;DR

Significant unexplained heterogeneity, low-to-very-low certainty of evidence, and the exclusively Chinese evidence base warrant cautious interpretation and limit generalizability.

Abstract

Objective To evaluate the effects of adjunctive hyperbaric oxygen therapy (HBOT) on cognitive, neurological, and functional outcomes in patients with post-stroke cognitive impairment (PSCI), and explore potential sources of heterogeneity. Methods Eight databases were searched from inception to July 15, 2026. Randomized controlled trials (RCTs) evaluating adjunctive HBOT in patients with PSCI were included. The primary outcome was the Montreal Cognitive Assessment (MoCA); secondary outcomes included the Mini-Mental State Examination (MMSE), National Institutes of Health Stroke Scale (NIHSS), Modified Barthel Index (MBI), and Barthel Index (BI). Random-effects meta-analyses, prespecified subgroup analyses, and meta-regression were performed. Sensitivity analyses, funnel plots, Egger’s tests, and GRADE assessments were conducted. Results Thirty-five RCTs involving 3,036 participants, all conducted in China, were included. Adjunctive HBOT was associated with higher MoCA scores (MD = 2.90, 95% CI: 2.47–3.33; p < 0.00001; I2 = 84%) and MMSE scores (MD = 2.68, 95% CI: 2.20–3.16; p < 0.00001; I2 = 83%). Improvements were also observed in NIHSS (MD = −2.61, 95% CI: −3.34 to −1.89; p < 0.00001; I2 = 93%), MBI (MD = 6.64, 95% CI: 3.76–9.52; p < 0.00001; I2 = 82%), and BI (MD = 8.77, 95% CI: 4.72–12.82;p < 0.00001; I2 = 82%). No statistically significant subgroup differences were observed for MoCA (p = 0.10) or MMSE (p = 0.43). Higher baseline MoCA scores tended to be associated with smaller treatment effects in meta-regression (β = −0.1411, p = 0.0637; R2 = 15.42%). Substantial heterogeneity remained largely unexplained. Evidence certainty was low for MoCA, MMSE, and MBI and very low for NIHSS and BI. Conclusion Adjunctive HBOT may provide cognitive and functional benefits in patients with PSCI. However, substantial unexplained heterogeneity, low-to-very-low certainty of evidence, and the exclusively Chinese evidence base warrant cautious interpretation and limit generalizability. Further well-designed RCTs involving diverse populations are needed. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420261473579, PROSPERO, CRD420261473579.

Read PDF

Similar papers

Review Oct 2026

Hyperbaric Oxygen Therapy for Physical and Cognitive Performance in Older Adults: A Systematic Review.

HBOT may improve cognitive performance in both healthy and clinical older adults and may offer modest benefits for physical performance, although physical improvements were sometimes inferred from functional or indirect measures.

M. Mohammadi, Amin Norouzi Fashkhami, A. Baghban · 0 citations
Review Open access Oct 2026

Effectiveness of hyperbaric oxygenation therapy in post-stroke dysphagia: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

Adjunctive HBO may improve swallowing function and related outcomes in PSD, but the clinical certainty is limited by methodological weaknesses, heterogeneity, incomplete reporting of intervention parameters, and insufficient TSA information size for several patient-centered outcomes.

Xiao-Guang Lin, Lin-Jing Wang, Min-Min Wu et al. · 0 citations
Review Open access Sep 2026

Efficacy and safety of oxiracetam for cognitive and functional outcomes after acute traumatic brain injury in Chinese populations: a systematic review and meta-analysis of randomized controlled trials

Background Oxiracetam is used in China for cognitive dysfunction after traumatic brain injury (TBI), but its efficacy and safety remain uncertain. We assessed oxiracetam in adults with acute TBI. Methods We searched six bibliographic databases and trial registries from inception through 28 February 2026, for randomized...

Mi-Mi Wang, Ning Cao, Zhang-Xuan Shou et al. · 0 citations
Review Open access Oct 2026

REVISITING HYPERBARIC OXYGEN THERAPY IN ACUTE MYOCARDIAL INFARCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CARDIAC RECOVERY AND SURVIVAL OUTCOMES

Hyperbaric oxygen therapy (HBOT) has been proposed as an adjunctive treatment in acute myocardial infarction (AMI) due to its potential to enhance oxygen delivery and attenuate ischemia–reperfusion injury. However, its clinical benefit in the era of modern reperfusion therapy remains uncertain. A systemati...

K. Zenjaya, Leoni, L. Handoko et al. · 0 citations
Meta-analysis Oct 2026

[Efficacy and clinical significance of choline alfoscerate in pre-dementia cognitive impairment. (A systematic review and meta-analysis of three randomized trials)].

OBJECTIVE To evaluate the efficacy of choline alfoscerate in mild cognitive impairment through a meta-analysis of randomized clinical trials considering potential sources of bias. MATERIAL AND METHODS A systematic search and meta-analysis were conducted, including three randomized controlled trials of choline alfosce...

A. Shmonin, I. Kashaev, G. S. Bakulin et al. · 0 citations
Review Open access Oct 2026

Efficacy and safety of minocycline in acute ischemic stroke: an updated systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

It is suggested that minocycline is biologically credible, but it did not demonstrate a consistent benefit in functional or neurological outcomes after AIS, and minocycline is viewed as a promising adjunct that now needs better targeted, biomarker-informed, reperfusion-aware trials rather than immediate universal use i...

M. Altaha, A. Abobaker, Muath Almuhanna et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.